Alcon posts results of Phase 3 FID 123320 study
The study enrolled 284 participants and was completed with results first posted on ClinicalTrials.gov on November 10, 2026. It assessed the safety and efficacy of FID 123320 Ophthalmic Solution (Apraclonidine HCl 0.125%) versus vehicle for relieving ocular redness in pediatric and adult populations.
Primary source
ClinicalTrials.gov results record, November 10, 2026
An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations
Read the source: An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation